scispace - formally typeset
G

Gonul Kanigur Sultuybek

Researcher at Istanbul Aydın University

Publications -  27
Citations -  363

Gonul Kanigur Sultuybek is an academic researcher from Istanbul Aydın University. The author has contributed to research in topics: Genotype & Metformin. The author has an hindex of 11, co-authored 27 publications receiving 271 citations. Previous affiliations of Gonul Kanigur Sultuybek include Istanbul University.

Papers
More filters
Journal ArticleDOI

NF-κB as the mediator of metformin's effect on ageing and ageing-related diseases.

TL;DR: This review underlines the pleiotropic effects of metformin in ageing and different ageing‐related diseases and attributes its effects to the modulation of NF‐kB.
Journal ArticleDOI

Polymorphism of the NFKB1 affects the serum inflammatory levels of IL-6 in Hashimoto thyroiditis in a Turkish population.

TL;DR: The findings suggest that the functional promoter NFKB1-94ins/del ATTG polymorphism was significantly associated with population HT disease through acting by directly modulating IL-6 serum levels.
Journal ArticleDOI

Association of Pre-miRNA-499 rs3746444 and Pre-miRNA-146a rs2910164 Polymorphisms and Susceptibility to Behcet's Disease

TL;DR: According to genotype analysis, the frequencies of ins/ins genotype and ins allele of rs28362491 were considerably higher in BD patients, and miRNA-499 rs3746444 homozygous (TT) genotypes exibited a significantly higher ri...
Journal ArticleDOI

The protective effects of metformin in an in vitro model of aging 3T3 fibroblast under the high glucose conditions

TL;DR: The data are consistent with the observation that metformin has a protective effect in this in vitro model of aging 3T3 fibroblasts under high glucose conditions inducing cell proliferation, collagen I and III production, protection from apoptosis, and reducing NF-kB(p65) activity.
Journal ArticleDOI

Association of PARP-1, NF-κB, NF-κBIA and IL-6, IL-1β and TNF-α with Graves Disease and Graves Ophthalmopathy

TL;DR: It is suggested that, PARP-1 and NFkB1 gene polymorphisms may be risk factors for developing Graves Disease and Ophthalmopathy.